Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from InhaleRx Limited ( (AU:IRX) ).
InhaleRx Limited announced a proposed issue of securities, including 15 million unlisted options and 30 million ordinary fully paid shares, set to be issued on November 28, 2025. This strategic move is expected to bolster the company’s financial position, potentially enhancing its market presence and providing additional capital for future growth initiatives.
More about InhaleRx Limited
InhaleRx Limited operates in the pharmaceutical industry, focusing on the development and distribution of inhalation-based drug delivery systems. The company aims to enhance therapeutic outcomes through innovative inhalation technologies, targeting various medical conditions.
Average Trading Volume: 257,297
Technical Sentiment Signal: Hold
Current Market Cap: A$7.85M
Learn more about IRX stock on TipRanks’ Stock Analysis page.